These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6304295)

  • 21. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter.
    Striessnig J; Zernig G; Glossmann H
    Eur J Biochem; 1985 Jul; 150(1):67-77. PubMed ID: 2990927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
    Bolger GT; Skolnick P
    Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P
    J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.
    Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN
    Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
    Glossmann H; Linn T; Rombusch M; Ferry DR
    FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart.
    Ferry DR; Glossmann H; Kaumann AJ
    Br J Pharmacol; 1985 Apr; 84(4):811-24. PubMed ID: 2408698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
    Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
    Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding properties of a novel calcium channel activating dihydropyridine in monolayer cultures of beating myocytes.
    Bellemann P
    FEBS Lett; 1984 Feb; 167(1):88-92. PubMed ID: 6199232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
    Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
    Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
    Kenny BA; Fraser S; Spedding M
    Br J Pharmacol; 1993 Jan; 108(1):93-9. PubMed ID: 7679034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations.
    Dacquet C; Loirand G; Rakotoarisoa L; Mironneau C; Mironneau J
    Br J Pharmacol; 1989 May; 97(1):256-62. PubMed ID: 2524235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. gamma-Aminobutyric acid release from synaptosomes as influenced by Ca2+ and Ca2+ channel blockers.
    Carvalho CM; Santos SV; Carvalho AP
    Eur J Pharmacol; 1986 Nov; 131(1):1-12. PubMed ID: 3816939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
    Maan AC; Hosey MM
    Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium channel antagonists and the treatment of migraine.
    Greenberg DA
    Clin Neuropharmacol; 1986; 9(4):311-28. PubMed ID: 2425960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
    Goll A; Ferry DR; Glossmann H
    FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.
    Ferry DR; Goll A; Glossmann H
    Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of [3H]-nitrendipine binding to uterine smooth muscle plasma membrane and its relevance to inhibition of calcium entry.
    Batra S
    Br J Pharmacol; 1985 Aug; 85(4):767-74. PubMed ID: 2412621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.